Grupp S, Maude S, Baruchel A, et al. Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities. 24th Congress of EHA, abstract S1618.
Brentuximab vedotine bij CD30-positief perifeer T-cellymfoom: resultaten na 5 jaar
apr 2022 | Lymfoom